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Selective targeting of cells for intracellular delivery of therapeutics represents a major challenge for pharmaceutical 
intervention in disease.  Here we show pH-triggered receptor-mediated endocytosis of nanoparticles via surface ligand 
exposure. Gold nanoparticles were decorated with two polymers: a 2 kDa PEG with a terminal folate targeting ligand, and 
a di-block copolymer including a pH-responsive and a hydrophilic block. At the normal serum pH of 7.4, the pH-responsive 
block (apparent pKa of 7.1) displayed a hydrophilic extended conformation, shielding the PEG-folate ligands, which 
inhibited cellular uptake of the nanoparticles. Under pH conditions resembling those of the extracellular matrix around 
solid tumours (pH 6.5), protonation of the pH-responsive polymer triggered a coil-to-globule polymer chain contraction, 
exposing folate residues on the PEG chains. In line with this, endocytosis of folate-decorated polymer-coated gold 
nanoparticles in cancer cells overexpressing folate receptor was significantly increased at pH 6.5, compared with pH 7.4. 
Thus, the tumour acidic environment and high folate receptor expression was effectively exploited to activate cell binding 
and endocytosis of these nanoparticles. These data provide proof-of-concept for strategies enabling extracellular pH 
stimuli to selectively enhance cellular uptake of drug delivery vectors and their associated therapeutic cargo.
Introduction 
Over the past few decades the exploitation of nanoscale carrier 
vehicles to improve the therapeutic efficacy of drugs has offered 
much promise for biomedical applications.
1, 2
 Poor
biopharmaceutical profiles of most anticancer drugs and their 
systemic toxicity have stimulated the development of novel 
strategies to provide site-specific delivery to tumours. 3 These 
approaches are aimed at preventing undesired off-target effects by 
prolonging, in the first instance, blood circulation time and 
increasing the drug deposition in the tumour. 4 The extended 
circulation of drug nanocarriers, achieved by tailoring their size and 
surface properties, has been shown also to affect significantly 
passive targeting to tumours. 5 This can be attributed, at least in
part, to the enhanced permeability and retention (EPR) effect which 
has been observed in animals and more recently implicated in some 
human cancers.
6-8
 However, by relying solely on this strategy, drug
release from the carrier can be limited in the extracellular disease 
site, and the poor permeability through biological membranes of 
therapeutics, especially macromolecules such as proteins and 
nucleic acids, further reduces the extent of intracellular drug 
accumulation.
4
 Carrier surface decoration with targeting moieties
for biorecognition of antigens or up-regulated receptors on the 
tumour cell plasma membrane (e.g., anti-transferrin receptor 
antibody, peptides for integrin binding, and receptors for small 
molecules such as folate and galactose) has been successfully 
exploited to enhance the intracellular access of drug delivery 
systems.
9-12
 A prototype of a successful actively targeted 
nanocarrier is CALAA-01, a transferrin-bearing cyclodextrin-based 
polymeric nanoparticle, which has been shown to deliver specific 
siRNAs intracellularly to exert their antitumour effects.
13
 However, 
pre-clinical studies have shown to date that the active targeting 
approach has had limited effects on the therapeutic performance of 
‘classical’ nanomedicines such as liposomes.
14, 15
 The lack of 
targeting in these cases has been ascribed to a variety of anatomical 
and physiological barriers that must be systematically and 
sequentially overcome before tumour localisation is achieved and 
cancer cell intracellular compartments are accessed. Recently, 
increasing understanding of the physio-pathology of solid tumours 
has stimulated the development of tailor-made micro-
environmentally sensitive nanocarriers with enhanced 
biorecognition properties. 3 Indeed, the peculiar physiological 
features of tumours compared to normal tissues, namely the lower 
extracellular pH, higher temperature and altered patterns of the 
extracellular enzymatic pool, have been regarded as opportunities 
to generate “smart” nanocarriers. 16 These are designed to exploit
synergistically temporal and local micro-environmental conditions 
to distribute selectively in the tumour tissue and be taken-up by 
cancer cells to reach the intracellular target. 17-21 This approach can
maximise the efficacy of the therapeutic treatment and minimise 
drug side effects.
19, 22
 Attempts have also been pursued to activate 
in situ the responsive systems by inducing environmental 
alterations with external focused stimuli including magnetic fields, 
heating, ultrasound and light. 19,21-24
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We have selected gold nanoparticles (AuNPs) as nanoscale 
constructs to prove the concept that drug delivery systems can be 
‘instructed’ to operate sequential tasks that are crucial to target 
cancer cells. Moreover, AuNPs were chosen in this study as a model 
nanoparticle platform by virtue of their ease of synthesis and 
surface decoration, but we believe our results have more general 
implications in the design of colloidal vehicles. AuNPs have a variety 
of biomedical applications, for example, in imaging, diagnostics, 
drug delivery, and cell sensitisation by external physical stimuli such 
as NIR laser light, ultrasound and X-rays. 
22-28
 Furthermore, drug-
coated gold nanoparticles have been recently demonstrated to 
reduce multidrug resistance (MDR) of anticancer drugs. 
29-31
We show here that the delivery of ligand-decorated polymer-
functionalised AuNPs to cancer cells can be enhanced by exploiting 
specific tumour-mimetic conditions, which in turn trigger 
conformational changes of polymers coating the AuNPs. This 
environmentally-controlled responsiveness of AuNPs leads to the 
site-selective exposure of recognition ligands that provide for active 
targeting of the AuNPs to specific cells.  This platform, in addition to 
being a versatile colloidal model, could also be exploited as 
sensitising agent that responds to external stimuli with enhanced 
site-selectivity for cancer therapeutic treatment. 
Experimental 
Materials and equipment. Synthesis of lipoyl-[(MCH)26-b-(GMA)53], 
OG-lipoyl-[(MCH)26-b-(GMA)50], lipoyl-(GMA)79, folate-PEG2kDa-SH 
(FA-PEG2kDa-SH), and Bodipy FL-PEG2kDa-SH (Bdp-PEG2kDa-SH), as well 
as production of naked AuNPs and characterisation of naked and 
polymer decorated AuNPs are described in the electronic 
supporting information (ESI). 
Evaluation of AuNP-polymer conjugation efficiency. Particles were 
incubated with increasing [polymer]:[AuNP] feed molar ratios to 
assess the efficiency of conjugation. 5.0 mg mL
-1 
FA-PEG2kDa-SH, a 
0.50 mg mL
-1 
Bdp-PEG2kDa-SH and a 10 mg mL
-1 
lipoyl-[(MCH)26-b-
(GMA)53] aqueous stock solutions were prepared. Samples of 3 nM 
AuNP suspensions were incubated with increasing molar excess of 
each polymer solution. More specifically, 3 nM AuNP suspensions 
(15 mL each) were added each respectively of 1.1, 2.2, 4.4, 11, 22, 
44, 66 and 132 µL of 5 mg mL
-1 
FA-PEG2kDa-SH solution in order to 
achieve [polymer]:[AuNP] feed molar ratios of 50:1, 100:1, 200:1, 
500:1, 1000:1, 2000:1, 3000:1 and 6000:1; 3 nM AuNP suspensions 
(15 mL) were added each respectively of 2.5, 5, 10, 20, 50, 100, 200, 
300 and 400 µL of 1 mg mL
-1 
Bdp-PEG2kDa-SH solution in order to 
achieve [polymer]:[AuNP] feed molar ratios of 25:1, 50:1, 100:1, 
200:1, 500:1, 1000:1, 2000:1, 3000:1 and 6000:1; 3 nM AuNP 
suspensions (15 mL) were added each respectively of 3.5, 7, 14, 35, 
70, 140, 210 and 420 µL of 10 mg mL
-1 
lipoyl-[(MCH)26-b-(GMA)53] 
solution in order to achieve [polymer]:[AuNP] feed molar ratios of 
50:1, 100:1, 200:1, 500:1, 1000:1, 2000:1, 3000:1 and 6000:1. Each 
polymer/AuNP mixture was brought to a final volume of 15.5 mL 
with Milli-Q water and incubated under rotational stirring at room 
temperature overnight. Afterwards, nanoparticles were isolated by 
centrifugation at 19720 x g for 30 min. Supernatants containing 
non-bound polymers were lyophilised and redissolved in 150 µL of 
Milli-Q water and tested by Iodine assay and UV-Vis spectroscopy 
after dilution (10 mM phosphate buffer, 137 mM NaCl, at pH 7.4 - 
PBS) at 363 nm to quantify FA-PEG2kDa-SH concentration, Iodine 
assay and UV-Vis spectroscopy (ethanol) at 503 nm to quantify Bdp-
PEG2kDa-SH concentration (Bodipy FL molar extinction coefficient in 
ethanol at λ503 nm = 80,000 M
−1
cm
−1
, as reported by the
manufacturer), and UV-Vis spectroscopy (0.02 N NaOH) at 300 nm 
to quantify lipoyl-[(MCH)26-b-(GMA)53 concentration. 
32, 33
 
Assembly of polymer-decorated AuNPs. 
Folate-targeted pH-responsive AuNPs: in a vial, 11 µL of a 0.50 mg 
mL
-1
 FA-PEG2kDa-SH solution (5.46 µg, 2.25 nmol) in water were 
mixed to 9 µL of a 50 µg mL
-1
 mPEG2kDa-SH solution in water (0.45
µg, 0.22 nmol). The mixture was added to a freshly prepared 3 nM 
AuNP suspension (15 mL) to yield a 50:5:1 [FA-PEG2kDa-
SH]:[mPEG2kDa-SH]:[AuNP] feed molar ratio. The AuNP suspension 
was incubated at room temperature under rotational stirring 
overnight in the dark. The particle suspension was centrifuged at 
19720 x g for 30 min, the AuNP pellet was washed twice with Milli-
Q water. The supernatants were pooled, lyophilised and redissolved 
in 150 µL of Milli-Q water and analysed by UV-Vis spectroscopy 
(PBS, pH 7.4) at 363 nm and by Iodine test at 535 nm to quantify 
the unbound FA-PEG2kDa-SH. Then the AuNP pellet was resuspended 
in 15 mL of water and added of 21 µL of a 0.50 mg mL
-1
 Bdp-
PEG2kDa-SH solution to yield a 100:1 [Bdp-PEG2kDa-SH]:[AuNP] feed 
molar ratio mixture. The suspension was left under rotational 
stirring overnight at room temperature in the dark. In order to 
recover the unbound Bdp-PEG2kDa-SH and assess its conjugation 
degree to AuNPs, the particle suspension was centrifuged and 
washed as described above, then the supernatant was lyophilised, 
redissolved in Milli-Q water and analysed by UV-Vis spectroscopy 
(ethanol) at λ=503 nm. Afterwards, the particle pellet was 
resuspended in 15 mL of Milli-Q water. The AuNP sample was 
added of 278 µL of a lipoyl-[(MCH)26-b-(GMA)53] solution in 0.02 N 
NaOH (8 mg mL
-1
) to yield a 3000:1 [lipoyl-[(MCH)26-b-
(GMA)53]]:[AuNP] feed molar ratio and the mixture was stirred 
overnight at room temperature in the dark. The particles were 
isolated by centrifugation at 19720 x g for 30 min, washed with 
Milli-Q water and centrifuged as described above and the 
supernatant was lyophilised, redissolved in 150 µL of Milli-Q water 
and analysed by UV-Vis spectroscopy (0.02 N NaOH) at 300 nm to 
quantify the amount of unbound lipoyl-[(MCH)26-b-(GMA)53. A 
reference mixture was also prepared with the same ratios and 
concentrations of polymers without AuNPs. The decoration 
efficiencies were derived by difference of the UV-Vis absorbances 
between the reference samples and the unbound polymers found 
in the supernatants of the AuNP containing samples.  
Non-targeted pH-responsive AuNPs: 9.9 µL of a freshly prepared 
0.50 mg mL
-1
 of mPEG2kDa-SH solution (4.95 µg, 2.47 nmol) was
added to 15 mL of freshly prepared 3 nM AuNP suspension to yield a 
55:1 [mPEG2kDa-SH]:[AuNP] feed molar ratio. Particle suspension 
was centrifuged at 19720 x g for 30 min, particles were washed with 
Milli-Q water as described above and the lyophilised supernatant 
was analysed by Iodine assay as described above to quantify the 
unbound PEG. Particles were then fluorescently labelled with Bdp-
PEG2kDa-SH and decorated with of lipoyl-[(MCH)26-b-(GMA)53] using 
the same procedure described for folate-targeted pH-responsive 
AuNPs. 
Folate-targeted non-pH-responsive AuNPs: gold nanoparticles were 
decorated with FA-PEG2kDa-SH and Bdp-PEG2kDa-SH as described for 
folate-targeted pH-responsive AuNPs. Afterwards, 178 µL of a 10 
mg mL
-1
 solution of lipoyl-(GMA)79 in Milli-Q water was added to 15
mL of freshly prepared 3 nM AuNP suspension in order to yield a 
3000:1 [lipoyl-(GMA)79]:[AuNP]  feed molar ratio. The mixture was 
stirred overnight at room temperature in the dark. The un-bound 
lipoyl-(GMA)79 was quantified by Iodine assay on the supernatant 
after particle centrifugation at 19720 x g for 30 min, lyophilisation 
and redissolution in 150 µL of Milli-Q water. 
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 Cell culture and viability assay. MCF-7 (human breast 
adenocarcinoma) and KB (human cervical carcinoma) cells were 
grown and tested for particle toxicity according to previously 
reported protocols (ESI).
27
Particle cell uptake by Atomic Absorption Spectroscopy. MCF-7 
and KB cells were seeded in 12-well plates at a density of 5 x 10
5 
cells per well and grown for 48 h. Then the medium was discharged, 
the cells were washed 3 times with PBS at pH 7.4 and incubated 
with 2 nM particle suspensions in FFDMEM at pH 7.4 and 6.5. After 
2 h of incubation at 37 °C in 5% CO2 atmosphere, the medium was 
removed and the cells were washed thrice with PBS. Cells were 
then detached by treatment with 1% (w/v) trypsin in PBS (150 
µL/well). Trypsin was quenched by adding 500 µL of PBS containing 
1 mM CaCl2 and MgCl2 and cell suspensions were centrifuged at 160 
x g for 5 min. Cell pellets were washed twice with PBS containing 1 
mM CaCl2 and MgCl2, then added of 0.1% Triton® X-100 in water 
(600 µL/sample) and treated with ultrasounds for 1 hr to induce 
lysis. Samples were centrifuged at 160 x g for 5 min. Cell lysates 
(500 µL) were digested by treatment with aqua regia (1:3 v/v 
HNO3/HCl, 5 mL) at 80 °C for 1 hour. The mineralised sample 
volumes were brought to 5 mL with 1% (w/v) HCl. Gold 
quantification was performed by Atomic Absorption Spectrometry 
(AAS). Gold concentration in the samples was normalised by the 
number of cells which was derived from a standard curve made by 
BCA Protein Assay (Thermo Fisher Scientific Inc., Waltham, MA-
USA) performed on 100 µL dilutions of cell lysate at known 
concentrations (cells/mL). 
Flow cytometric analysis. KB cells were seeded in 12-well plates at 
a density of 3 x 10
5
 cells per well and allowed to adhere and grow 
for 48 h under tissue culture conditions. The medium was replaced 
with 2 nM particle suspensions in FFDMEM at pH 7.4 or 6.5. Cells 
were incubated for 2 h at 37 °C in a humidified 5% CO2 atmosphere 
and then washed thrice with 1 mL PBS and detached by 4 min 
treatment with 1% (w/v) trypsin in PBS (150 μL/well) at 37 °C. 
Trypsin activity was quenched by adding 500 μL of PBS containing 1 
mM CaCl2 and MgCl2 and cells were recovered by centrifugation at 
160 x g for 5 min. Cells were then fixed in freshly prepared 4% (w/v) 
paraformaldehyde (PFA) in PBS for 15 min at room temperature, 
centrifuged at 160 x g for 5 min, washed once with PBS and 
resuspended in 300 µL of PBS. The samples were analysed at 
λex=488 nm, λem=525 nm using a BD FACSDiva flow cytometer 
(Becton, Dickinson and Company, Buccinasco, Milan) and the 
results were processed with BD FACSDiva Software. Cell 
competition assay was performed by incubating KB cells with 
particle suspensions in FFDMEM at pH 7.4 or 6.5 containing 200 μM 
folic acid. After 2 h incubation time, the samples were processed as 
described above. 
Confocal microscopy. MCF-7 and KB cells were seeded onto 35 mm 
glass bottom dishes (MatTek, Ashland, US) at a seeding density of 
1.5 x 10
5
 cell per well in FFDMEM containing 15% FBS and grown for 
48 h under tissue culture conditions. The medium was removed, 
cells were washed thrice with 1 mL of PBS and incubated with 2 nM 
particle suspensions in FFDMEM at pH 7.4 and 6.5 (250 μL/dish) at 
37 °C in the dark for 2 h. Particle samples were then removed and 
wells were gently washed with PBS (1 mL x 3). Cells were incubated 
in pre-warmed imaging medium (phenol red-free DMEM pH 7.4 
containing 25 mM HEPES and supplemented with 1 mg mL
-1
 BSA). 
Cells were imaged on a Leica TCS SP5 confocal laser-scanning 
microscope using 488 nm laser excitation of Bodipy FL.  
Cell competition assay was performed by incubating KB cells with 
Folate-targeted pH-responsive AuNPs in FFDMEM for 2 h at pH 7.4 
or 6.5 enriched of 200 μM folic acid. The samples were imaged and 
analysed as above.   
Transmission electron microscopy (TEM). Intracellular disposition 
of AuNPs was imaged by TEM analysis. KB cells were seeded at the 
density of 3 x 10
5
 cells per well in 12 well plates and allowed to
adhere and grow for 48 h under tissue culture conditions. Cells 
were incubated with 2 nM particle suspensions in FFDMEM at pH 
7.4 and 6.5 for 2 h at 37 °C.  The incubation medium was removed 
and cells were washed thrice with 1 mL PBS and fixed with 2.5 % 
(w/v) glutaraldehyde in 0.1 M sodium cacodylate buffer at 4 ˚C for 1 
hr. The cells were washed twice with sodium cacodylate buffer and 
post fixed in 0.1 M sodium cacodylate buffer containing 1% (w/v) 
osmium tetroxide for 1 hr, dehydrated using ethanol and 
embedded in fresh EPON resin. Ultrathin sections of the samples 
were cut and observed with a Tecnai G2 Transmission Electron 
Microscope (FEI, Oregon, USA).  
Statistical analysis. All experiments were carried out three times 
and each sample was generated in triplicate. Data are presented as 
mean ± S.E calculated from three independent experiments. 
Statistical analyses were performed with GraphPad software. 
Statistical comparisons between treatment groups were performed 
with analysis of variance (one-way ANOVA) and the threshold of 
significance was calculated according to Bonferroni’s test. Statistical 
significance was attained for values of p<0.05. 
Results and discussion 
This proof of concept study aimed to enhance the site-selectivity of 
nanoparticles to a tumour environment. The extracellular pH of 
many solid tumour tissues is typically in the 6-7 range, thus more 
acidic than most healthy tissues, due to modification of cancer cell 
energetic metabolism.
34, 35 The hypoxic condition is one of the
major causes that drive tumour cells to metabolise glucose 
abnormally in the glycolytic pathway. Accordingly, the high 
production of lactic acid and proton pump activity lead to 
acidification of the tumour extracellular environment.
34, 36
 
Our approach is aimed at exploiting this gradient of pH as an 
‘on/off’ switch whereby functional ligands on NPs are hidden under 
conditions mimicking those found in systemic circulation, but which 
can be subsequently exposed in the more acidic tumour 
microenvironment, thus enhancing selectivity for specific cancer 
cells. With this purpose, pH-responsive polymers were chosen that 
would shield the surface of NPs at physiological pH, then shrink 
under more acidic conditions, revealing the ligands of choice (Figure 
1). Accordingly, the study was carried out by using three main 
components: AuNPs, folic acid as model targeting agent and a pH-
responsive di-block copolymer. A fluorescent tag, Bodipy FL, was 
also conjugated to the AuNPs as tracer for biological investigations.  
AuNPs were chosen as model colloidal systems because they can be 
easily manufactured and then modified with multiple components 
through the formation of strong metal-sulfur bond.
37
 Previous
studies have shown that hydrophilic polymer-coated AuNPs with a 
core size of less than 20 nm exhibit prolonged blood half-life 
compared to larger particles, thus in this work AuNPs with an 
average diameter of 15 nm were used.
38
 Folic acid is commonly
used to selectively target cancer cells that overexpress the folate 
receptor; this promotes cell uptake through receptor mediated 
endocytosis.
39, 40
 Finally, a pH-responsive block copolymer based on
3-chloro-4-hdroxybenzoic esters was used to generate AuNPs able
to undergo surface structural changes induced by pH variations in
the physio-pathological range of healthy and tumour tissue, set
here at pH 7.4 and 6.5 respectively.
41-43
Page 3 of 10
Figure 1. Hide-and reveal smart AuNPs. Left. Chemical structures of the three 
polymeric components used to assemble the nanosystem: FA-PEG2kDa-SH, Bdp-
PEG2kDa-SH and lipoyl-[(MCH)26-b-(GMA)53]. Right. Schematic representation of 
the responsive AuNPs: at physiological pH (7.4) the responsive copolymer is in 
the extended conformation which masks the targeting agent FA-PEG2kDa-SH; at 
acidic pH (6.5) of the tumour, lipoyl-[(MCH)26-b-(GMA)53] collapses, which 
exposes the targeting agent that can bind the folate receptor and guide particle 
internalisation. 
Synthesis of coating materials. 
Folic acid was conjugated to the particle surface through a flexible 
PEG2kDa-SH spacer which was calculated to have a fully extended 
chain length of 18 nm.
44  
Notably, PEGylated liposomes currently 
used in the clinic (Doxil® and Caelyx®) are produced with a 2 kDa 
PEG corona to minimise vesicle opsonisation and complement 
activation that results in prolonged blood circulation time.
 6, 45 
Accordingly, folate-PEG2kDa-SH (FA-PEG2kDa-SH, Figure 1) with a ω-
sulfhydryl group suitable for conjugation to AuNPs was synthesised 
by reacting N-hydroxysuccinimidyl-ester activated folic acid (FA-
NHS) with NH2-PEG2kDa-SH using a 3:1 FA-NHS/NH2-PEG2kDa-SH 
molar ratio in order to maximise the PEG derivatisation (Scheme 
S1). After purification and treatment with TCEP to reduce the 
disulfide species formed during the synthesis of FA-PEG2kDa-SH, a 
96% chain-end fidelity in thiol groups was found. Structurally 
analogous green fluorescent Bdp-PEG2kDa-SH (Figure 1), was 
synthesised to fluorescently tag AuNPs and facilitate their tracking 
during in vitro cell studies. Bdp-PEG2kDa-SH (λex 503 nm, λem 509 nm) 
was obtained by conjugating N-hydroxysuccinimidyl ester activated 
Bodipy FL (Bdp-NHS) to NH2-PEG2kDa-SH (Scheme S2). A 2 kDa PEG 
linker was chosen as previous studies showed that a spacers with a 
length longer than 6 nm,  corresponding to an extended PEG chain 
with a molecular weight of 0.75 kDa, are needed to prevent 
fluorescence quenching induced by the gold surface.
46
A novel Au-reactive lipoyl-poly[2-(methacryloyloxy)ethyl-3-chloro-4-
hydroxybenzoate]-b-[glycerol methacrylate] (lipoyl-[(MCH)26-b-
(GMA)53]) copolymer (Figure 1) was designed for this work to 
bestow AuNPs with pH induced surface conformational changes in 
the physio-pathological range of blood and tumour tissue. Notably, 
the 2-(methacryloyloxy)ethyl-3-chloro-4-hydroxybenzoate (MCH) 
monomer was selected by virtue of its substituted phenol group 
pKa with a value ~7. This is prevalently in its anionic hydrophilic 
state at pH 7.4, while it protonates and converts into a neutral 
hydrophobic form under acidic conditions.
42
The length selection of each polymeric component used to coat the 
particles and the individual blocks of the responsive copolymer was 
key to allow the hide-and-reveal of the FA-PEG2kDa-SH targeting 
agent. Accordingly, the pH-responsive lipoyl-[(MCH)26-b-(GMA)53] 
copolymer with a calculated chain-extended length of 25.5 nm (10.7 
nm length of the pH-responsive polyMCH block and 14.8 nm length 
of the hydrophilic non-responsive polyGMA block) was synthesised. 
At physiological pH, the two blocks were expected to be hydrophilic 
due to the presence of hydrated glycerol and ionised 3-chloro-4-
hydroxybenzoate side-chains, and assume an extended 
conformation, allowing for the shielding of the shorter FA-PEG2kDa-
SH targeting agent (Figure 1, pH 7.4). We hypothesised that under 
the acidic conditions often found in solid tumour environments, 
protonation of the 3-chloro-4-hydroxybenzoate residues would 
cause the polyMCH block to become hydrophobic, inducing a 
transition of these polymer chains from extended coils to collapsed 
globule-like conformations on the AuNP surface (Figure 1, pH 6.5). 
In turn, this would result in an overall shortening of the 
lipoyl[(MCH)26-b-(GMA)53] chains, and unmasking of the folate-
targeting agents.  
A lipoic ester chain-end was chosen because of its ability to form 
stable S-Au bonds, and to be inert under the radical polymerisation 
conditions utilised to prepare these copolymers.
47
 Accordingly, 
lipoyl-[(MCH)26-b-(GMA)53] was generated by RAFT polymerisation 
using a novel chain-transfer agent (CTA) that was designed to 
control the polymerisation process and introduce a lipoic acid 
moiety at the polymer α-chain end (Scheme 1A). 
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Scheme 1. (A) Synthesis of lipoyl-CTA. I.a. Oxalyl chloride, DCM 0 °C. I.b. TEG, 
Et3N, DCM. II. 4-cyano-4-(phenylcarbonothioylthio) pentanoic acid/DCC/DMAP, 
DCM 0 °C. Synthesis of the lipoyl-[(MCH)26-b-(GMA)53]. III. MCH, AIBN, DMF 70 °C. 
IV. GMA, AIBN, DMF 70 °C. V. AIBN, DMF 70 °C. (B) Synthesis of the lipoyl-
(GMA)79.
Lipoic acid was first converted into its corresponding acid chloride 
with oxalyl chloride, then esterified with an excess of tetraethylene 
glycol (TEG) and finally conjugated to 4-cyano-4-
(phenylcarbonothioylthio) pentanoic acid using DCC/DMAP to yield 
the desired lipoyl-CTA. The di-block copolymer lipoyl-[(MCH)26-b-
(GMA)53]-CTA was synthesised by polymerisation of 2-
(methacryloyloxy) ethyl-3-chloro-4-hydroxybenzoate monomer 
(MCH) in the presence of lipoyl-CTA and then utilising the resulting 
lipoyl-(MCH)26-CTA as macro transfer agent for the subsequent 
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polymerisation of hydrophilic glycerol methacrylate (GMA). Finally, 
removal of the dithiobenzoic end groups from lipoyl-[(MCH)26-b-
(GMA)53]-CTA was carried out according to the procedure 
developed by Perrier et al., using an excess of AIBN at 80 °C in DMF 
for 4 h and resulted in the disappearance of the pink colour from 
the isolated final polymer.
48, 49
We have previously shown that the ability of polyMCH-based 
copolymers to undergo hydrophilic/hydrophobic switching depends 
on both polymer composition- i.e. chemical structure and relative 
molar ratio of the monomers and molecular weight of their 
individual blocks.
42
 In particular, we found that a poly(MCH-b-GMA) 
copolymer with a degree of polymerisation  of 80 and a MCH/GMA 
ratio of 1:2 underwent morphological rearrangement in the 7.4-6.5 
pH range, required in the present study. Moreover, preliminary 
studies performed by exposing AuNPs decorated with poly(MCH-b-
GMA) possessing a 1:2 MCH/GMA ratio to pH 7.4 and 6.5 showed 
the particle stability at both pH conditions. However, a higher MCH 
ratio in the polymer backbone led to AuNP aggregation at pH 6.5 
which is undesirable for in vitro/in vivo applications.  
A non-pH-responsive polymer, lipoyl-(GMA)79, with the same total 
number of repeating units as lipoyl-[(MCH)26-b-(GMA)53] was 
synthesised to produce ‘control’ folate-targeted non-pH-responsive 
AuNPs (Scheme 1B).  
pH-responsiveness of lipoyl-[(MCH)26-b-(GMA)53]. 
The pKa of the pH-responsive copolymer was determined by 
potentiometric acid/base titration and back titration. In agreement 
with previous reports, Figure 2A shows that, a decrease of pH 
induced reversible protonation of MCH repeating units.
42, 50
 In turn, 
this prompted an increase of the hydrophobicity of the polyMCH 
block that resulted in reversible self-assembly.
42
 This likely 
prevented access of the titrant to all phenolic groups of polyMCH, 
thus partially interfering with the titration process, hence the pKa 
7.1 measured in these experiments is referred to here as “apparent 
pKa”.  
Figure 2. (A) Potentiometric Titration (●) and back titration (●) profiles of lipoyl-
[(MCH)26-b-(GMA)53]. (B) Turbidimetric profile (●) of lipoyl-[(MCH)26-b-(GMA)53]. 
Turbidimetric analysis was performed to assess the polymer cloud 
point (CP) corresponding to its phase-separation in solution. CP is a 
descriptor of the material aggregation behaviour that stems from 
the increased hydrophobicity of the polyMCH as the pH decreases, 
which ultimately leads to formation of visible aggregates, which 
occurred at pH 5.2 (Figure 2B). The observed pKa and CP values of 
the copolymer were found to be in reasonable agreement with the 
estimated LogD values of MCH (LogD at pH 7.4 = 3.29; LogD at pH 
6.5 = 3.71). This supported the increase in hydrophobicity of the pH-
sensitive monomer as the pH decreases from pH 7.4 to 6.5.
51 
Thus, protonation of MCH monomers under acid conditions causes 
the polyMCH blocks of the pH responsive polymer to become more 
hydrophobic. It should be noted that the self-assembly process of 
the lipoyl-[(MCH)26-b-(GMA)53] is observed upon gradual 
acidification of aqueous solutions, where polymer chains are free to 
assemble into nanostructures (Supporting information, Table S1). 
However, at the surface of AuNPs the mobility of polymer chains is 
restricted due to their lipoic ester chain-end being chemically linked 
to the gold surface. As a result, chain-chain assembly should be 
prevented, and lowering of pH will result in an increase of the 
hydrophobicity of the individual polyMCH blocks, their dehydration, 
and consequent collapse to minimise contact area with water, thus 
exposing FA-PEG2kDa-SH ligands via a hide and reveal mechanism. 
Assembly and characterisation of folate-targeted pH-responsive 
AuNPs.  
In order to set-up a suitable coating protocol, initial preliminary 
studies were carried out to assess the conjugation efficiency of each 
polymeric component to AuNPs.  
The FA-PEG2kDa-SH, Bdp-PEG2kDa-SH and lipoyl-[(MCH)26-b-(GMA)53] 
coating efficiencies, defined as polymer chains/nm
2
, were 
calculated by spectrophotometric quantification of the unbound 
polymers after conjugation to AuNPs. Figure 3A shows that the 
maximal densities of FA-PEG2kDa-SH and Bdp-PEG2kDa-SH on the gold 
surface were 1.2 polymer chain/nm
2
 for both polymers in 
agreement with the density values reported in literature for PEG of 
comparable molecular weight.
52
 [FA-PEG2kDa-SH]:[AuNP] and [Bdp-
PEG2kDa-SH]:[AuNP] feed molar ratios below 200:1 in the coating 
process yielded over 90% of polymer conjugation. The maximal 
lipoyl-[(MCH)26-b-(GMA)53] density on the AuNP surface was 1.10 
chains/nm
2
, which was very similar to FA-PEG2kDa-SH and Bdp-
PEG2kDa-SH. [Lipoyl-[(MCH)26-b-(GMA)53]]:[AuNP]  feed molar ratios 
below 200:1 also yielded over 90% coating efficiency.  
The folate-targeted pH-responsive AuNPs were then obtained 
following a three-step procedure: i) surface modification with FA-
PEG2kDa-SH, ii) fluorescent labelling with Bdp-PEG2kDa-SH, iii) surface 
saturation with the pH-responsive copolymer lipoyl-[(MCH)26-b-
(GMA)53].  
In the first step, the particles were functionalised using a 50:1 [FA-
PEG2kDa-SH]:[AuNP] feed molar ratio. Our previous studies 
demonstrated that 18 nm AuNPs functionalised with 50 folate 
molecules/particle possessed high binding avidity to immobilized 
receptors and were efficiently internalised by KB cells 
overexpressing the folate receptor.
52
 This degree of folate labelling 
was shown to promote the highest cell uptake of nanoparticles with 
respect to lower and higher densities, which was ascribed to 
multivalent clustering of folate receptors on cell.
53, 54
However, the AuNP coating with FA-PEG2kDa-SH was found to yield 
unstable particles that prevented their handling in subsequent 
derivatisation steps. This may be attributed to the hydrophobicity 
of folate. In order to overcome the stability problems, a 5:50 
[mPEG2kDa-SH]:[FA-PEG2kDa-SH]:[AuNP] feed molar ratio mixture was 
used. In the second step, 100:1 [Bdp-PEG2kDa-SH]:[AuNP] feed molar 
ratio was used to label the nanoparticles. Finally, in the third step 
the particle surface was saturated with the pH-responsive 
copolymer using a 3000:1 [lipoyl-[(MCH)26-b-(GMA)53]]:[AuNP] feed 
molar ratio.  
Each coating step was followed by particle purification by 
centrifugation and spectrometric determination of the unbound 
polymers in the supernatant. Polymer conjugation efficiency was 
found to be 97%, 95% and 13% for FA-PEG2kDa-SH, Bdp-PEG2kDa-SH 
and lipoyl-[(MCH)26-b-(GMA)53], respectively, which corresponded 
to a mean of 48, 95 and 390 polymer chains per AuNP, respectively. 
The calculated total polymer density was 0.75 chains/nm
2
, which is
slightly lower than that obtained by the direct conjugation of the 
single polymers. This result suggests that the presence of polymers 
on the nanoparticle surface during the multi-step coating can 
hinder the subsequent insertion of further polymer chains thus 
limiting the final coating efficiency. The observed low lipoyl-
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[(MCH)26-b-(GMA)53] conjugation efficiency here is simply due to 
the large excess of polymer used to maximise polymer density at 
the particle surface. 
Control non-targeted pH-responsive AuNPs and control folate-
targeted non-pH-responsive AuNPs were prepared following an 
analogous protocol, using mPEG2kDa-SH instead of FA-PEG2kDa-SH or 
by using lipoyl-(GMA)79 instead of lipoyl-[(MCH)26-b-(GMA)53], 
respectively. 
The concentration of the AuNP samples in suspension was 
calculated by UV-Vis analysis at λ=506 nm (ε506 nm = 3.62 ∙ 10
8
 M
-1 
cm
-1
, Figure 3B). Importantly, at this wavelength there is no 
appreciable absorption of FA-PEG2kDa-SH and lipoyl-[(MCH)26-b-
(GMA)53] and the absorption of Bdp-PEG2kDa-SH is negligible (ε506 nm 
= 80,000 M
-1
 cm
-1
) compared to that of AuNPs.
Dynamic light scattering (DLS) and transmission electron 
microscopy (TEM) analyses were performed to characterise size and 
morphological features of both naked and polymer-decorated 
AuNPs.  
DLS size distributions (Figure 3E) showed that the size of AuNPs 
increased upon polymer conjugation; the size expressed as intensity 
(Table S2) shows that the particle size increases from 19.5±3.8 to 
54.4±20.1 nm for naked and folate-targeted pH-responsive AuNPs 
at pH 7.4, respectively. Folate-targeted pH-responsive AuNPs 
maintained a narrow size distribution, with a polydispersity index 
(PDI) of 0.34±0.08. The control non-targeted pH-responsive 
particles and folate-targeted non-pH-responsive particles at pH 7.4 
showed DLS profiles similar to the folate-targeted pH-responsive 
AuNPs at pH 7.4, with a mean size of 52.5±16.5 and 56.6±19.9 nm, 
respectively (Supporting Information, Table S2 and Figure S21). At 
pH 6.5, the folate-targeted non-pH-responsive particles showed DLS 
profiles similar to the folate-targeted pH-responsive AuNPs at pH 
7.4. DLS analysis of folate-targeted pH-responsive AuNPs at pH 6.5 
showed an unexpectedly high mean particle size of 77.2±18.7 nm 
that could be explained with an AuNP association due to the MCH 
protonation in the lipoyl-[(MCH)26-b-(GMA)53] polymer (Supporting 
Information, Table S2 and Figure S21).  
Figure 3. (A) Polymer density on particles surface at increasing [polymer]:[AuNP] 
feed molar ratio in the initial optimization experiments: FA-PEG2kDa-SH (♦), 
poly(MCH-co-GMA) (▲), Bdp-PEG2kDa-SH (■). (B) Absorption spectra of naked 
AuNPs (▬) and folate-targeted pH-responsive AuNPs (▬) in Milli-Q water.  TEM 
images of (C) naked and (D) folate-targeted pH-responsive AuNPs in 10 mM PBS 
at pH 7.4. Scale bars: 50 nm. (E) DLS size distribution profiles referred as intensity 
% of naked AuNPs (■) and folate-targeted pH-responsive AuNPs (■) in 10 mM PBS 
at pH 7.4.  
TEM analysis was carried out to elucidate the morphological and 
dimensional features of the nanoparticles and their pH induced 
coating rearrangement.   
TEM analyses showed that at pH 7.4 both naked and functionalised 
AuNPs had a spherical smooth shape (Figure 3C and 3D). Notably, 
the folate-targeted pH-responsive particles possess a grey corona 
surrounding the particle core further confirming the presence of a 
polymeric coating. TEM image elaboration of naked and folate-
targeted pH-responsive AuNPs by ImageJ software displayed mean 
sizes of 19.1±1.5 nm and 48.9±3.2 nm, respectively.  
Figure 4. TEM images of folate-targeted pH-responsive AuNPs in 10 mM PBS at 
pH 7.4 (A) and 6.5 (B). Scale bars: 20 nm. 
The TEM analysis (Figure 4) confirmed the hypothesis that the pH-
responsive polymer corona thickness on particle surface is reduced 
(35.5±2.9 nm)  by shrinkage when exposed at pH 6.5 mimicking the 
tumour environment while the control folate-targeted non-pH-
responsive particles did not show significant size differences at pH 
7.4 and 6.5 (41.0±3.0 nm and 40.5±3.1 nm, respectively). TEM 
analyses showed the tendency of folate-targeted pH-responsive 
AuNPs to form small associations at pH 6.5 which may explain the 
unexpected increase of the particles size observed by DLS analysis 
at pH 6.5. However, even when folate-targeted pH-responsive 
AuNPs are associated, the pH-responsive polymer shrinking on 
particle surface was observed (Supporting Information, Figure S22). 
Particle stability studies were performed by incubating folate-
targeted pH-responsive AuNPs in folate-free DMEM medium 
(FFDMEM) at pH 7.4 and 6.5. Sizes observed by DLS analyses of 
particle suspensions over a 4 h period were found to remain 
constant at both pH values. Notably, folate-targeted pH-responsive 
AuNPs showed a mean particle size of 58.7±17.3 nm and 82.1±24.2 
nm at pH 7.4 and 6.5, respectively.  
An additional assay was performed to further investigate the 
morphological alterations of the pH-responsive polymer bound on 
the particle surface in response to pH changes. It is has been 
reported that substantial quenching of fluorescent molecules can 
take place when the dye is in the proximity of a metal nanoparticle 
surface.
55, 56
 In particular, AuNPs with a size of 10-15 nm showed a 
massive loss in fluorescence when the distance of the fluorophore 
from the particle surface was below 6 nm.
46
 Moreover, Acuna et al. 
clearly demonstrated that a decrease in the fluorescence signal 
could already be detected when the distance of the dye from the 
metal NPs surface was 14 nm, and that this was also negatively 
affecting the fluorophore lifetime. This phenomenon was exploited 
here to investigate polymer shrinkage at the surface of polymer-
modified gold nanoparticles. A fluorescent pH-responsive polymer 
analogous to lipoyl-[(MCH)26-b-(GMA)53] was synthesised by 
including an oregon green methacrylate monomer (OGM) in the 
polyGMA hydrophilic block yielding OG-lipoyl-[(MCH)26-b-(GMA)50] 
(synthesis and characterisation are described in Supporting 
information). Oregon Green was chosen as fluorescent probe 
because of its lower pKa (typically in the 4.3-4.8 range) compared to 
other fluorescein-based dyes, which makes its fluorescence 
properties non pH-dependent, under the conditions utilised in this 
study (pH 6.5 and 7.4).
57
 The incubation of the OG-lipoyl-[(MCH)26-
b-(GMA)50] coated AuNPs at pH 6.5 induced a remarkable decrease 
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of the particle fluorescence intensity, compared to that observed at 
pH 7.4, which was ascribed to the collapse of the polyMCH block 
causing the oregon green to get closer to the particle surface 
(Figure 5). Notably, the free OG-lipoyl-[(MCH)26-b-(GMA)50] in 
solution did not show fluorescence intensity alteration at pH 7.4 
and 6.5 (Figure S18). 
Figure 5. Fluorescence emission spectra of OG-lipoyl-[(MCH)26-b-(GMA)50] coated 
AuNPs at pH 7.4 (left) and 6.5 (right). Excitation wavelength was set at 496 nm. 
The top figure illustrates the morphological rearrangement of the polymer on the 
particle surface upon acidification from pH 7.4 to 6.5, and the resulting Oregon 
green fluorescence quenching. 
In vitro biological studies 
Cell viability 
Cell viability studies were performed using MCF-7 human breast 
cancer and KB human cervical carcinoma cell lines to evaluate the 
cytocompatibility of the folate-targeted pH-responsive AuNPs at pH 
7.4 and 6.5 (Figure 6). These two cell lines represent, respectively, 
low (lowFR) and high (hiFR) expressing folate receptor in in vitro 
models.
58
 In both cell lines, cell metabolic activity (as a proxy for 
viability) after 24 h incubations was >85% at the two pH values for 
all selected folate-targeted pH-responsive AuNP concentrations 
utilised (0.2-2 nM). 
Similar results were obtained with the control non-targeted pH-
responsive (with mPEG2kDa-SH instead of FA-PEG2kDa-SH), and folate-
targeted non-pH-responsive (lipoyl-(GMA)79 instead of lipoyl-
[(MCH)26-b-(GMA)53) AuNPs (electronic supporting information, 
Figure S24). 
Figure 6. Cell viability profile of KB (A) and MCF-7 (B) cells incubated with 
increasing concentration of folate-targeted pH-responsive AuNPs at pH 7.4 (□) 
and 6.5 (●) for 24 h. 
Environmentally controlled cell uptake of particles 
The assay was performed by incubating KB and MCF-7 cells with 2 
nM functional AuNPs for 2 h. AuNP cell uptake was investigated by 
atomic absorption spectrometry, flow cytometry, confocal 
microscopy and transmission electron microscopy. 
Atomic absorption spectrometry. Results showed that at pH 6.5 the 
uptake of the folate-targeted pH-responsive AuNPs in KB cells was 
~3-fold higher than at pH 7.4 (Figure 7). The particle association 
with this cell line (8926 AuNPs /cell) was  analogous to that found in 
previous studies where AuNPs decorated with folate-cysteamine 
were utilised.
52
 The pH dependent cell uptake supports the 
hypothesis that at physiological pH (7.4) the lipoyl-[(MCH)26-b-
(GMA)53] is hydrophilic with an extended conformation that confers 
“stealth” properties to the nanosystem and hides the folate ligand 
from binding to the folate receptor. At acidic conditions, the 
increased polyMCH block hydrophobicity due to the protonation of 
the phenolic hydroxyl groups induces the pH-responsive block 
collapse on the particle surface resulting in copolymer shortening 
and consequent exposure of the targeting agent. The zeta potential 
of folate-targeted pH-responsive AuNPs and non-targeted pH-
responsive AuNPs was -5.8 and -2.7 mV at pH 7.4 and -1.9 and -1.1 
mV at pH 6.5, respectively. The slight decrease of zeta potential at 
pH 6.5 did not translate in the association of the control non-
targeted pH-responsive AuNPs neither to KB nor MCF-7 cells, which 
proved that the association to KB cells is not driven by the limited 
decrease of the absolute value of particle zeta potential occurring 
when the polyMCH block of lipoyl-[(MCH)26-b-(GMA)53] is 
increasingly neutralised. In MCF-7 cells, negligible AuNP uptake was 
observed at both pHs confirming that the AuNP internalisation was 
mediated by folate receptor recognition that takes place only when 
the pH-responsive polymer collapses. Crucially, incubation of 
control particles, non-targeted pH-responsive, and targeted non-
pH-responsive AuNPs, did not show any appreciable uptake, further 
confirming that the observed AuNPs uptake was mediated by the 
folate receptor. Lipoyl-(GMA)79 is expected to have the same chain 
length of lipoyl-[(MCH)26-b-(GMA)53] but, lacking pH-responsive 
repeating units, it remains in its extended conformation at all pH 
values tested, thus efficiently masking the particle folate ligands. 
Notably, the results obtained with folate-targeted AuNPs decorated 
with non-responsive polymer lipoyl-(GMA)79 confirmed that for the 
AuNPs investigated, hide and reveal mechanism was crucial to 
achieve efficient cell uptake. 
Figure 7. Cell uptake of folate-targeted pH-responsive AuNPs (■), non-targeted 
pH-responsive AuNPs (■) and folate-targeted non-pH-responsive AuNPs (■) at pH 
7.4 and pH 6.5 by KB cells (A) and MCF-7 cells (B). Particles/cell was quantified by 
atomic absorption spectrometry on cell lysates. Statistical significance was 
calculated versus folate-targeted pH-responsive AuNP uptake at pH 6.5: *** 
p<0.001. 
Flow cytometry. Cell uptake profile of polymer-decorated AuNPs 
was also investigated by flow cytometric analysis. Whilst not 
providing the absolute number of AuNPs internalised with each cell, 
this technique allowed comparison of the relative uptake of the 
different functional AuNPs. Figure 8 shows the association of non-
targeted pH-responsive AuNPs, folate-targeted non-pH-responsive 
A) B) 
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gold nanoparticles and folate-targeted pH-responsive gold 
nanoparticles at pH 7.4 and 6.5.  
Figure 8. Flow cytometric profile at pH 7.4 (A-D) and 6.5 (A’-D’) and mean 
fluorescence intensity (MFI) of KB cells (E) incubated with non-targeted pH-
responsive AuNPs (Non-FA pH-resp. AuNPs), folate-targeted non-pH-responsive 
AuNPs (FA non-pH-resp. AuNPs) and folate-targeted pH-responsive AuNPs (FA 
pH-resp. AuNPs) at pH 7.4 (striped bars) and 6.5 (solid bars). Statistical 
significance was calculated versus folate-targeted pH-responsive AuNPs at pH 
6.5: *** p<0.001. 
Again, significant uptake was observed only for folate-targeted pH-
responsive AuNPs at pH 6.5, in complete agreement with the results 
obtained in the atomic absorption spectroscopy experiments. 
Confocal microscopy and TEM imaging. Confocal microscopic 
images of live cells Figure 9 showed that folate-targeted pH-
responsive AuNPs were selectively and efficiently taken up by KB 
cells at pH 6.5, while at pH 7.4 very little cell-associated 
fluorescence was observed. In contrast, control non-targeted pH-
responsive AuNPs underwent a much lower level of internalisation, 
again confirming the need for appropriate display of folate ligands 
to achieve efficient endocytosis. In an analogous manner, control 
folate-targeted non-pH-responsive AuNPs showed negligible cell 
association at both pH values, further confirming that lipoyl-
(GMA)79 coating could effectively mask the folate ligands on the 
particles. Importantly, the confocal images taken at the midpoint of 
the cells also revealed that the targeted particles were internalised 
by cells rather than confined on the cell membrane (electronic 
supporting information, Figure S25).  
KB cells were also incubated with folate-targeted pH-responsive 
AuNPs in the presence of folic acid to assess specificity (Figure 9). 
Successful competition and thus reduced AuNP uptake was clearly 
detected when KB cells were incubated with folate-targeted pH-
responsive AuNPs in the presence of folic acid at pH 6.5. This study 
further confirms that the folate-targeted pH-responsive AuNPs 
uptake is mediated by the specific binding of the exposed folate 
ligand of particles to the cell receptor. However, at pH 7.4 only a 
weak fluorescence was observed, which was further decreased in 
the presence of the competing free folic acid. This suggests that the 
limited particle uptake at pH 7.4 may be in part due to a residual 
specific binding to the folate receptor.  
Figure 9. Confocal microscopic images of KB cells incubated with folate-targeted 
pH-responsive AuNPs (FA pH-resp. AuNPs), non-targeted pH-responsive AuNPs 
(Non-FA pH-resp. AuNPs), folate-targeted non-pH-responsive AuNPs (FA non-pH-
resp. AuNPs) and  FA pH-resp. AuNPs in the presence of 200 µM competing folic 
acid (FA pH-resp. AuNPs + FA) at pH 6.5 and 7.4. Fire LUT using ImageJ software 
was applied to the confocal images to visualize pixel intensity. Scale bars: 30 µm. 
Transmission electron microscopy (TEM). Finally, ultrastructural 
disposition of AuNPs was investigated by TEM imaging of KB cells. 
Figure 10A and 10B show that at pH 6.5 the folate-targeted pH-
responsive AuNPs were clearly visible inside KB cells.  
Notably, the folate-targeted pH-responsive AuNPs are localised in 
membrane-limited intracellular compartments with no evidence of 
major aggregation, demonstrating that the hydrophilic and flexible 
polyGMA outer corona inhibited the particle aggregation.  
Figure 10. TEM images of folate-targeted pH-responsive AuNPs incubated with KB 
cells at pH 6.5 (A) and pH 7.4 (C). Red arrowheads point at AuNPs. Panel B and D 
are magnifications of the white squares in panel A and C, respectively.  
Cells incubated with the folate-targeted pH-responsive AuNPs at pH 
7.4, however, showed very little evidence of uptake although some 
particles could still be observed on the plasma membrane (Figure 
10C and 10D). This low level of binding with no apparent uptake 
may account for the cell-associated particles detected under these 
conditions by atomic absorption spectroscopy and flow cytometric 
analyses at pH 7.4.  
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Conclusions 
This proof-of-principle study shows that colloidal systems with 
dynamic surfaces can enhance site-selectivity for targeting cancer 
cells with high expression of plasma membrane receptors. 
Accordingly, these results suggest that physio-pathologic conditions 
of the extracellular tumour environment and cancer cell plasma 
membrane signature can be synergistically exploited to drive 
nanoparticle targeting and internalisation. 
Importantly, the present work suggests that by finely programming 
the dynamic surface properties of nanosystems, site-selectivity can 
be significantly enhanced, thus reducing the disposition of drug 
nanocarriers and their often toxic payloads to off-target tissues. The 
tumour acidity-triggered ‘hide and reveal’ concept explored has 
potential for translation to a variety of colloidal carriers in a number 
of cancer settings.  
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